Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-05 18:00 |
Amoéba: a first half-year mainly marked by the development of the biocontrol pl…
|
English | 404.2 KB | ||
| 2023-09-22 18:00 |
AMOEBA : dernières étapes d’avancement du projet d’usine 100% biocontrôle à Cav…
|
French | 376.1 KB | ||
| 2023-09-22 18:00 |
AMOEBA: final stages of development of 100% biocontrol plant in Cavaillon
|
English | 365.4 KB | ||
| 2023-08-04 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d'actions
|
French | 257.6 KB | ||
| 2023-07-13 08:30 |
AMOEBA : Calendrier réglementaire de l’application biocontrôle en Europe confor…
|
French | 474.7 KB | ||
| 2023-07-13 08:30 |
AMOEBA: Regulatory timetable for Europe''s biocontrol application on track
|
English | 580.4 KB | ||
| 2023-07-04 17:45 |
AMOEBA : Bilan semestriel du contrat de liquidité
|
French | 583.0 KB | ||
| 2023-07-04 17:45 |
Amoéba : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | 428.1 KB | ||
| 2023-06-08 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d’actions
|
French | 106.8 KB | ||
| 2023-06-05 17:45 |
AMOEBA dévoile sa marque AXPERA pour l’application biocontrôle
|
French | 504.6 KB | ||
| 2023-06-05 17:45 |
AMOEBA introduces its AXPERA brand for the biocontrol application
|
English | 528.8 KB | ||
| 2023-05-26 17:45 |
AMOEBA : Descriptif du programme de rachat d’actions autorise par l’Assemblée G…
|
French | 438.3 KB | ||
| 2023-04-20 17:45 |
AMOEBA announces the initiation of coverage by Portzamparc - BNP Paribas Group
|
English | 437.4 KB | ||
| 2023-04-20 17:45 |
AMOEBA annonce l’initiation de couverture de son titre par Portzamparc – Groupe…
|
French | 459.2 KB | ||
| 2023-04-19 17:45 |
AMOÉBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 25 MAY 2023
|
English | 280.4 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
